WO2006088824A3 - Compounds useful for treating hiv - Google Patents

Compounds useful for treating hiv Download PDF

Info

Publication number
WO2006088824A3
WO2006088824A3 PCT/US2006/005096 US2006005096W WO2006088824A3 WO 2006088824 A3 WO2006088824 A3 WO 2006088824A3 US 2006005096 W US2006005096 W US 2006005096W WO 2006088824 A3 WO2006088824 A3 WO 2006088824A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating hiv
compounds useful
compounds
useful
treating
Prior art date
Application number
PCT/US2006/005096
Other languages
French (fr)
Other versions
WO2006088824A2 (en
Inventor
Bahige Baroudy
Jean Archambault
Original Assignee
Millenia Hope Pharmaceuticals
Bahige Baroudy
Jean Archambault
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millenia Hope Pharmaceuticals, Bahige Baroudy, Jean Archambault filed Critical Millenia Hope Pharmaceuticals
Priority to EP06734977A priority Critical patent/EP1848443A2/en
Priority to CA002597935A priority patent/CA2597935A1/en
Publication of WO2006088824A2 publication Critical patent/WO2006088824A2/en
Publication of WO2006088824A3 publication Critical patent/WO2006088824A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Compounds, e.g., of the Formulae (Ia), (Ib) and (Ic) are useful for treating HIV infection.
PCT/US2006/005096 2005-02-15 2006-02-14 Compounds useful for treating hiv WO2006088824A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06734977A EP1848443A2 (en) 2005-02-15 2006-02-14 Compounds useful for treating hiv
CA002597935A CA2597935A1 (en) 2005-02-15 2006-02-14 Compounds useful for treating hiv

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65274205P 2005-02-15 2005-02-15
US60/652,742 2005-02-15

Publications (2)

Publication Number Publication Date
WO2006088824A2 WO2006088824A2 (en) 2006-08-24
WO2006088824A3 true WO2006088824A3 (en) 2009-04-23

Family

ID=36916970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/005096 WO2006088824A2 (en) 2005-02-15 2006-02-14 Compounds useful for treating hiv

Country Status (4)

Country Link
EP (1) EP1848443A2 (en)
CN (1) CN101500419A (en)
CA (1) CA2597935A1 (en)
WO (1) WO2006088824A2 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No relevant documents disclosed *

Also Published As

Publication number Publication date
CA2597935A1 (en) 2006-08-24
WO2006088824A2 (en) 2006-08-24
EP1848443A2 (en) 2007-10-31
CN101500419A (en) 2009-08-05

Similar Documents

Publication Publication Date Title
WO2008127364A3 (en) Antiviral compounds and use thereof
WO2008115281A3 (en) Compounds for treating viral infections
AU2005235116A1 (en) Combinations for treating HIV infection
HK1113085A1 (en) Compounds, compositions and methods for the treatment of poxvirus infections
WO2008054676A3 (en) Medical devices and methods of using the same
WO2006104945A3 (en) Hepatitis c therapies
WO2006124713A3 (en) 4-biarylyl-1-phenylazetidin-2-ones
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
WO2007133290A3 (en) Anti-ox40l antibodies and methods using same
AP2006003525A0 (en) Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia.
WO2005115398A3 (en) Hiv integrase inhibitors
AP2005003366A0 (en) Pyrimidine derivatives for the prevention of HIV infection.
MY152503A (en) 4-phenyl-pyrane-3, 5-diones, 4-phenyl-thiopyrane-3, 5-diones and cyclohexanetriones as novel herbicides
WO2007030567A3 (en) Pparactive compounds
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
WO2006072615A3 (en) Triazolophthalazines as pde2-inhibitors
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2007070613A3 (en) Rifamycin analogs and uses thereof
WO2009042114A3 (en) Phenazine derivatives and uses thereof
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
WO2006034035A3 (en) Treatment of ischemia
TW200621160A (en) Anti-termite agent
WO2007127506A8 (en) Anti-ephrinb2 antibodies and methods using same
WO2005097787A3 (en) Novel benzothiazoles and the use thereof as medicaments

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680004795.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007555329

Country of ref document: JP

ENP Entry into the national phase in:

Ref document number: 2597935

Country of ref document: CA

NENP Non-entry into the national phase in:

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006734977

Country of ref document: EP